For this supplement, expert faculty provided detailed perspectives based on their extensive experience in the management of non–small-cell lung cancer (NSCLC), focusing on the incorporation and considerations for biomarker testing in precision medicine.
August 2026 | Volume 19 | No 3
To sign up for our newsletter or print publications, please enter your contact information below.
